title: A Woman With Treatment-Resistant Hypertension.
authors.affiliation: From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.C., C.D., R.M.T., A.F.D.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (G.L.R.J.); and Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.). Gemma.Currie@glasgow.ac.uk.
authors.forename: Gemma
authors.initials: G
authors.lastname: Currie
authors.affiliation: From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.C., C.D., R.M.T., A.F.D.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (G.L.R.J.); and Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.).
authors.forename: Christian
authors.initials: C
authors.lastname: Delles
authors.affiliation: From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.C., C.D., R.M.T., A.F.D.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (G.L.R.J.); and Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.).
authors.forename: Rhian M
authors.initials: RM
authors.lastname: Touyz
authors.affiliation: From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.C., C.D., R.M.T., A.F.D.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (G.L.R.J.); and Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.).
authors.forename: Jan A
authors.initials: JA
authors.lastname: Staessen
authors.affiliation: From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.C., C.D., R.M.T., A.F.D.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (G.L.R.J.); and Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.).
authors.forename: Anna F
authors.initials: AF
authors.lastname: Dominiczak
authors.affiliation: From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.C., C.D., R.M.T., A.F.D.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (G.L.R.J.); and Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.).
authors.forename: Garry L R
authors.initials: GL
authors.lastname: Jennings
authors.affiliation: From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.C., C.D., R.M.T., A.F.D.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (G.L.R.J.); and Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.).
authors.forename: Ji-Guang
authors.initials: JG
authors.lastname: Wang
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008991:Monitoring, Physiologic
chemical_list: D000959:Antihypertensive Agents